Kinaxis to Host Inaugural European User Conference Showcasing Supply Chain Innovators
17.9.2025 14:00:00 EEST | Business Wire | Press release
Kinaxis® Inc. (TSX: KXS), a global leader in end-to-end supply chain orchestration, today announced its inaugural customer conference in Europe. Kinexions EMEA 2025 will be held October 6 – 8 in Amsterdam NL, bringing together global supply chain leaders from ExxonMobil, Bosch, and more.
Following the success of Kinexions conferences in North America and Asia, expanding Kinexions into Europe meets the needs of a growing customer community in the region and reflects the growing community of leaders in the region who are driving some of the most innovative and resilient supply chain transformations today. That momentum is reflected in Kinaxis’ 18% year-over-year revenue growth in Europe, underscoring rising demand for AI-driven orchestration on the Kinaxis Maestro® platform.
Why It Matters
As supply chains face ongoing pressure from the dynamic tariff environment, geopolitical risk, ESG regulation, and many other disruptions, companies are accelerating digital transformation efforts. Kinexions EMEA will showcase how concurrent planning, real-time orchestration, and agentic AI are helping global brands build resilient and responsive supply chains. Attendees will also hear from experts in new sessions on decision intelligence and orchestration at scale, highlighting how these innovations are transforming planning, forecasting, and operational strategy.
“Our customers across EMEA are leading some of the most complex supply chain transformations in the world,” said Fabienne Cetre, executive vice president, EMEA at Kinaxis. “Bringing Kinexions to Amsterdam reflects the strength of that community and creates a space to share real-world lessons, challenge assumptions, and shape the future of supply chain orchestration together.”
What to expect at Kinexions EMEA 2025
Attendees can expect a rich, three-day experience featuring:
- Mainstage Keynotes: Executives from ExxonMobil, Bosch, and other leaders reveal how they are reshaping supply chains to build resilience and agility.
- Special Guest Keynote: Join world-renowned futurist Gerd Leonhard as he explores the 3 Revolutions - digital, green, and purpose-driven - that are reshaping our world. Discover how exponential technologies, sustainability, and human values will redefine the next decade and why the future is already here.
- Three Breakout Tracks:
- Product Innovation – Showcasing the latest Maestro capabilities
- Customer Success – Real-world results from global manufacturers
- Emerging Trends – Exploring AI, sustainability, digitization, and more
- Executive Forum: Peer discussions for senior leaders in automotive, CPG, and life sciences, focused on growth, risk and transformation
- Co-Innovation Labs: Hands-on sessions to explore new product capabilities and shape future roadmap priorities
- Women’s Leadership Breakfast: Spotlighting the future of supply chain talent and representation across EMEA
Kinexions EMEA 2025 is supported by industry partners including Diamond Sponsor Genpact, which is sponsoring the welcome reception and executive track, and Platinum Sponsors Accenture and Deloitte, who are co-hosting the community celebration and hosting dedicated happy hour receptions.
Who Should Attend
Kinexions EMEA is open to supply chain professionals of all levels, from strategic planners and transformation leaders to operational managers and analysts. Attendees will gain actionable insights, connect with peers across the region, and leave with new tools to navigate volatility, scale innovation, and drive results.
Registration & Agenda
Learn more and register for Kinexions EMEA.
About Kinaxis
Kinaxis is a leader in modern supply chain orchestration, powering complex global supply chains and supporting the people who manage them. Our powerful, AI-infused supply chain orchestration platform, Maestro, combines proprietary technologies and techniques that provide full transparency and agility across the entire supply chain — from multi-year strategic planning to last-mile delivery. We are trusted by renowned global brands to provide the agility and predictability needed to navigate today’s volatility and disruption. For more news and information, please visit kinaxis.com or follow us on LinkedIn.
Source: Kinaxis Inc
View source version on businesswire.com: https://www.businesswire.com/news/home/20250917551922/en/
Contacts
Media Relations
Matt Tatham | Kinaxis
mtatham@kinaxis.com
+1 917-446-7227
Investor Relations
Rick Wadsworth | Kinaxis
rwadsworth@kinaxis.com
+1 613-907-7613
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Imagine Dragons to Perform at Abu Dhabi Grand Prix21.5.2026 18:51:00 EEST | Press release
Ethara, organiser of the Formula 1 Etihad Airways Abu Dhabi Grand Prix, have announced that one of the world’s biggest bands, Imagine Dragons, will headline the Saturday After-Race Concerts at the F1 Season Finale in Abu Dhabi. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521214839/en/ Imagine Dragons to perform at Formula 1 Etihad Airways Abu Dhabi Grand Prix (Photo: AETOSWire) The announcement is another landmark moment for the Abu Dhabi Grand Prix, whose thrilling Yasalam presented by e& fan entertainment offering has become synonymous with the F1 Championship finale in Abu Dhabi and is recognised as one of the most compelling sports and entertainment crossovers globally. The global chart-toppers join Lewis Capaldi and Zara Larsson, who are set to kick off a blockbuster line-up of performances on Yas Island on Thursday, 3 December, with more major international artists to be revealed. With their popular top hits, Ima
Otovo Hits 30,000 Customers in Under a Year, Tackling the Growing ‘Solar Service Crisis’21.5.2026 17:25:00 EEST | Press release
Otovo ASA (“Otovo”), a leading global energy service provider for residential and commercial customers, today announced it has reached 30,000 customers across the U.S. and Europe. A total of 20,000 customers have enrolled in Otovo Care, the Company’s membership-based home and commercial energy service, which is powered by Otovo’s industry-leading AI platform, Endurance™. “Reaching 30,000 customers in less than year is proof positive that home and business owners value their power systems,” said William J. (John) Berger, CEO of Otovo. “The ‘solar service crisis’ that is leaving millions of orphaned energy systems without support is driving strong interest in our Otovo Care membership program. Every day your home or commercial power system is not working, you are throwing money away. Otovo’s rapid response service platform keeps you up and running, ensuring your investment is delivering.” The rapid growth of the residential solar market created a growing population of “orphaned” solar sy
Carnegie Mellon University and Cleveland Clinic Develop AI System to Interpret Cardiac MRI Scans with Enhanced Accuracy21.5.2026 15:05:00 EEST | Press release
A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s Cardiovascular Innovation Research Center, has developed an artificial intelligence (AI) system capable of interpreting some of the most complex heart scans in medicine, cardiac magnetic resonance imaging (MRI), without the need for manually labeled training data. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521762286/en/ A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s Cardiovascular Innovation Research Center, has developed an artificial intelligence (AI) system capable of interpreting some of the most complex heart scans in medicine, cardiac magnetic resonance imaging (MRI), without the need for manually labeled training data. The novel system, called CMR-CLIP, is designed to interpret cardiac MRI scans by connecting moving images of the heart with corresponding clinical radio
The Live Moment Effect: Genius Sports and MediaScience Study Finds Specific Moments in Live Sports Can Double Unaided Brand Recall21.5.2026 15:00:00 EEST | Press release
Genius Sports Limited (NYSE: GENI), a global leader in real-time sports data, today released new biometric research conducted with MediaScience showing that ads delivered immediately after emotionally heightened moments in live sports can double unaided brand recall. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521475265/en/ The Live Moment Effect report from Genius Sports and MediaScience. The study, The Live Moment Effect, finds that advertising effectiveness is significantly influenced by a viewer’s emotional state immediately before an ad is shown. In controlled biometric testing, ads shown after high-intensity sporting moments, such as near-scoring plays or crucial momentum shifts, delivered approximately double the unaided brand recall of baseline conditions. The Moment Before the Ad Matters The research challenges long-held assumptions about media value, showing that not all impressions are equal. Live sports rem
Merck Announces First Patient Dosed in Phase 3 Study for Investigational Antibody-Drug Conjugate in Colorectal Cancer21.5.2026 15:00:00 EEST | Press release
Merck, a leading science and technology company, today announced that the first patient has been dosed in the Phase 3 PROCEADE®-CRC-03 trial (NCT07549412). The study is evaluating precemtabart tocentecan (Precem‑TcT), a potential first‑in‑class investigational anti‑CEACAM5 antibody‑drug conjugate (ADC), for the treatment of metastatic colorectal cancer (mCRC). “Leveraging our novel payload‑linker technology, Precem‑TcT is the first CEACAM5‑targeted ADC in clinical studies with an exatecan payload, rationally designed for stability and enhanced cancer cell killing activity,” said David Weinreich, MD, MBA, Global Head of R&D and Chief Medical Officer for the Healthcare business of Merck. “The Phase 3 study and the enrollment of the first patient with Precem-TcT build on the Company’s more than 20 years of expertise in colorectal cancer, and highlight our commitment to advancing differentiated ADCs for heavily pretreated patients with limited treatment options.” The PROCEADE®-CRC-03 study
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom